Telemetry Investments, L.L.C. Xtant Medical Holdings, Inc. Transaction History

Telemetry Investments, L.L.C.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$0.82 - $1.63 $119,833 - $238,206	-146,139 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$0.76 - $1.6 $45,164 - $95,083	-59,427 Reduced 28.91%	146,139 $120,000
Q2 2020 Aug 14, 2020	SELL	$0.62 - $1.74 $339,182 - $951,898	-547,068 Reduced 72.69%	205,566 $185,000
Q1 2020 May 15, 2020	SELL	$0.63 - $1.64 $177 - $460	-281 Reduced 0.04%	752,634 $504,000
Q4 2019 Feb 14, 2020	SELL	$1.55 - $2.89 $28,862 - $53,814	-18,621 Reduced 2.41%	752,915 $1.21 Million
Q3 2019 Nov 14, 2019	SELL	$2.41 - $3.05 $26,071 - $32,994	-10,818 Reduced 1.38%	771,536 $2.19 Million
Q2 2019 Aug 14, 2019	BUY	$2.45 - $3.5 $32,930 - $47,043	13,441 Added 1.75%	782,354 $2.35 Million
Q1 2019 May 15, 2019	SELL	$2.09 - $4.45 $58,338 - $124,212	-27,913 Reduced 3.5%	768,913 $2.35 Million
Q4 2018 Feb 14, 2019	BUY	$1.61 - $4.0 $101,557 - $252,316	63,079 Added 8.6%	796,826 $1.28 Million
Q3 2018 Nov 14, 2018	BUY	$3.85 - $6.2 $2.82 Million - $4.55 Million	733,747 New	733,747 $2.83 Million

98.2M

Ticker XTNT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 108,226,000
Market Cap $49.8M
Description
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.